You are invited to learn about Lung Cancer Treatment Breakthroughs at @Perlmutter_CC @nyulangone Thursday December 11, 2025 6-7PM EST @StermanDaniel, Benjamin Cooper, Harvey Pass, Abraham Chachoua. i.nyulangone.org/vl6
Joshua Sabari, MD
@JSabari
Thoracic medical oncologist, Perlmutter Cancer Center NYU Langone Health. Tweets are my own and not medical advice
863 Following 2.1K Followers 213 Posts
Latest posts 5
FDA approval for lung cancer med Hernexeos fiercepharma.com/pharma/boehrin… @Perlmutter_CC @nyulangone @EGFRResisters @Exon20Group
www.fiercepharma.com Boehringer Ingelheim breaks into oncology with FDA approval for lung cancer med Hernexeos With the FDA approval of its zongertinib in certain non-small cell lung cancer (NSCLC) patients, 175-year-old Boehringer Ingelheim is entering the oncology market. | Zongertinib got an accelerated... 
Honored to be an Expert Judge Mentor for #EGFRSummit! Submit your abstracts by 8/8 to be part of the next class of @EGFRSummit Young Investigators! ➡️ ce.ceconcepts.com/EGFR2025CFA
#EGFR #LCSM #MedTwitter #MedEd
#EGFR #LCSM #MedTwitter #MedEd
Getting excited for ASCO 2025! Join us Sat, May 31 at The Sheraton Grand Chicago Riverwalk in Chicago 6 Ballroom for #PrecisionMedicine in #NSCLC at #ASCO25! 6:30 PM CDT Reg & Dinner | 7 PM CDTSymposium. @PeerView @LUNGevity @OncBrothers ➡️ bit.ly/25TT-T
www.peerview.com Precision Matters in NSCLC: Everything You Need to Know About Biomarker Testing and Targeted... See a new #NSCLC activity via @PeerView @glopesMD @OncBrothers #ASCO #MedEd